Clinical Outcomes of HER2‐Low Versus HER2‐Zero in HR‐Positive Metastatic Breast Cancer Treated With Endocrine Therapy With or Without CDK4/6 Inhibitors: A Multicenter Retrospective Study.
Saved in:
| Title: | Clinical Outcomes of HER2‐Low Versus HER2‐Zero in HR‐Positive Metastatic Breast Cancer Treated With Endocrine Therapy With or Without CDK4/6 Inhibitors: A Multicenter Retrospective Study. |
|---|---|
| Authors: | Susiriwatananont, Thiti1 (AUTHOR), Wongkraisri, Concord2 (AUTHOR), Dajsakdipon, Thanate3 (AUTHOR), Supavavej, Archara4 (AUTHOR), Dechaphunkul, Arunee5 (AUTHOR), Sunpaweravong, Patrapim5 (AUTHOR), Neesanun, Sunee6 (AUTHOR), Ithimakin, Suthinee2 (AUTHOR), Dejthevaporn, Thitiya3 (AUTHOR), Parinyanitikul, Napa1 (AUTHOR) napaparinyanitikul@gmail.com, Tyagi, Abhishek (AUTHOR) atyagi@wakehealth.edu |
| Source: | International Journal of Breast Cancer. 11/4/2025, Vol. 2025, p1-13. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
